{"transactions":[{"id":4627221,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91900,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":4627220,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":500,"price":13.505,"value":6752.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026."}],"balance_after":69828,"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":4627219,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":100,"price":13.5,"value":1350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026."}],"balance_after":70328,"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":4627218,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":true,"shares":600,"price":4.36,"value":2616.0,"ownership":{"direct":true},"balance_after":70428,"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":672987,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":120000,"derivative":{"exercise_price":6,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672986,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":false,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92500,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672985,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":77000,"price":13.6859,"value":1053814.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026."}],"balance_after":69828,"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672984,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":6,"value":150000.0,"ownership":{"direct":true},"balance_after":146828,"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672983,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":52000,"price":4.36,"value":226720.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":121828,"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":879695,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-26T21:47:24.000Z","date":"2026-02-24","kind":"exercise","planned":true,"acquired":false,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144500,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001695028-26-000004","document":"form4-02262026_090218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000004/form4-02262026_090218.xml","form_type":"4"}},{"id":879694,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:47:24.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":52000,"price":13.5132,"value":702686.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 52,000 shares sold in the price range of $13.50 to $13.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68148,"source":{"system":"sec-edgar","filing":"0001695028-26-000004","document":"form4-02262026_090218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000004/form4-02262026_090218.xml","form_type":"4"}},{"id":879693,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:47:24.000Z","date":"2026-02-24","kind":"exercise","planned":true,"acquired":true,"shares":52000,"price":4.36,"value":226720.0,"ownership":{"direct":true},"balance_after":120148,"source":{"system":"sec-edgar","filing":"0001695028-26-000004","document":"form4-02262026_090218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000004/form4-02262026_090218.xml","form_type":"4"}},{"id":946816,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:42:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."}],"balance_after":34500,"derivative":{"underlying":"Common Stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0001695028-26-000002","document":"form4-01062026_090131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000002/form4-01062026_090131.xml","form_type":"4"}},{"id":946815,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:42:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":206500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":206500,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":206500},"source":{"system":"sec-edgar","filing":"0001695028-26-000002","document":"form4-01062026_090131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000002/form4-01062026_090131.xml","form_type":"4"}},{"id":965071,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965070,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965069,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965068,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":10720,"price":9.0604,"value":97127.488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0396 to $9.1953 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68148,"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965067,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":29333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,218 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":78868,"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":1021475,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-08T21:37:17.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":196500,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001695028-25-000004","document":"form4-10082025_091013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000004/form4-10082025_091013.xml","form_type":"4"}},{"id":1021474,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-08T21:37:17.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":14.5199,"value":159718.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 11,000 shares sold in the price range of $14.50 to $14.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48317,"source":{"system":"sec-edgar","filing":"0001695028-25-000004","document":"form4-10082025_091013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000004/form4-10082025_091013.xml","form_type":"4"}},{"id":1021473,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-08T21:37:17.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":4.36,"value":47960.0,"ownership":{"direct":true},"balance_after":59317,"source":{"system":"sec-edgar","filing":"0001695028-25-000004","document":"form4-10082025_091013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000004/form4-10082025_091013.xml","form_type":"4"}},{"id":1095225,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-02T20:07:16.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":10.0486,"value":200972.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $10.00 to $10.135 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48317,"source":{"system":"sec-edgar","filing":"0001415889-25-019000","document":"form4-07022025_080708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925019000/form4-07022025_080708.xml","form_type":"4"}},{"id":1102658,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-24T22:33:12.000Z","date":"2025-06-24","kind":"sale","planned":true,"acquired":false,"shares":32466,"price":10.5045,"value":341039.097,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 32,466 shares sold in the price range of $10.34 to $10.80 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68317,"source":{"system":"sec-edgar","filing":"0001415889-25-018128","document":"form4-06242025_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925018128/form4-06242025_100608.xml","form_type":"4"}},{"id":1102657,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-24T22:33:12.000Z","date":"2025-06-23","kind":"sale","planned":true,"acquired":false,"shares":450,"price":10.01,"value":4504.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":100783,"source":{"system":"sec-edgar","filing":"0001415889-25-018128","document":"form4-06242025_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925018128/form4-06242025_100608.xml","form_type":"4"}},{"id":1102656,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-24T22:33:12.000Z","date":"2025-06-23","kind":"sale","planned":true,"acquired":false,"shares":584,"price":10,"value":5840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":101233,"source":{"system":"sec-edgar","filing":"0001415889-25-018128","document":"form4-06242025_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925018128/form4-06242025_100608.xml","form_type":"4"}},{"id":1111672,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-13T23:38:23.000Z","date":"2025-06-12","kind":"sale","planned":true,"acquired":false,"shares":300,"price":10,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":101817,"source":{"system":"sec-edgar","filing":"0001415889-25-017325","document":"form4-06132025_110620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925017325/form4-06132025_110620.xml","form_type":"4"}},{"id":1114953,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:37:51.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":10.01,"value":17017.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":102117,"source":{"system":"sec-edgar","filing":"0001415889-25-016739","document":"form4-06112025_100647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016739/form4-06112025_100647.xml","form_type":"4"}},{"id":1114952,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:37:51.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":1276,"price":10,"value":12760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":103817,"source":{"system":"sec-edgar","filing":"0001415889-25-016739","document":"form4-06112025_100647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016739/form4-06112025_100647.xml","form_type":"4"}},{"id":1114951,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:37:51.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":324,"price":10,"value":3240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,553 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":105093,"source":{"system":"sec-edgar","filing":"0001415889-25-016739","document":"form4-06112025_100647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016739/form4-06112025_100647.xml","form_type":"4"}},{"id":1117902,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T00:18:27.000Z","date":"2025-06-09","kind":"sale","planned":true,"acquired":false,"shares":300,"price":10,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":103864,"source":{"system":"sec-edgar","filing":"0001415889-25-016386","document":"form4-06102025_120617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016386/form4-06102025_120617.xml","form_type":"4"}},{"id":1117901,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T00:18:27.000Z","date":"2025-06-06","kind":"sale","planned":true,"acquired":false,"shares":2600,"price":10.0082,"value":26021.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 2,600 shares sold in the price range of $10.00 to $10.04 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":104164,"source":{"system":"sec-edgar","filing":"0001415889-25-016386","document":"form4-06102025_120617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016386/form4-06102025_120617.xml","form_type":"4"}},{"id":1314853,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T22:41:54.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-25-000601","document":"form4-01032025_100150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925000601/form4-01032025_100150.xml","form_type":"4"}},{"id":1314852,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:41:54.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":202500,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001415889-25-000601","document":"form4-01032025_100150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925000601/form4-01032025_100150.xml","form_type":"4"}},{"id":1328788,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328787,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328786,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6042},"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328785,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":8851,"price":8.2813,"value":73297.7863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 8,851 shares sold in the price range of $8.28 to $8.41 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":106764,"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328784,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":true,"shares":24042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":115615,"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1692610,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:18:59.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-24-000364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919124000364/doc4.xml","form_type":"4"}},{"id":1692609,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:18:59.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":180000,"derivative":{"exercise_price":9.14,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-24-000364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919124000364/doc4.xml","form_type":"4"}},{"id":1704929,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-20T00:40:41.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-23-059264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123059264/doc4.xml","form_type":"4"}},{"id":1704928,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-20T00:40:41.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":6042,"derivative":{"underlying":"Common Stock","underlying_shares":6042},"source":{"system":"sec-edgar","filing":"0001209191-23-059264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123059264/doc4.xml","form_type":"4"}},{"id":1704927,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:40:41.000Z","date":"2023-12-15","kind":"sale","planned":false,"acquired":false,"shares":5282,"price":8.5835,"value":45338.047,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 5,282 shares sold in the price range of $8.57 to $8.756 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":83809,"source":{"system":"sec-edgar","filing":"0001209191-23-059264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123059264/doc4.xml","form_type":"4"}},{"id":1704926,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:40:41.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":14042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":89091,"source":{"system":"sec-edgar","filing":"0001209191-23-059264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123059264/doc4.xml","form_type":"4"}},{"id":2007711,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-17T21:23:48.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":2227,"price":3.0777,"value":6854.0379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."}],"balance_after":67285,"source":{"system":"sec-edgar","filing":"0001209191-23-010611","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123010611/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-16"}},{"id":2036193,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-02T21:11:20.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":24000,"derivative":{"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-23-006195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123006195/doc4.xml","form_type":"4"}},{"id":2036192,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T21:11:20.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":145000,"derivative":{"exercise_price":6,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001209191-23-006195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919123006195/doc4.xml","form_type":"4"}},{"id":2083738,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-17T01:49:24.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":12084,"derivative":{"underlying":"Common Stock","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001209191-22-061755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122061755/doc4.xml","form_type":"4"}},{"id":2083737,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-17T01:49:24.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":2089,"price":3.25,"value":6789.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."}],"balance_after":67423,"source":{"system":"sec-edgar","filing":"0001209191-22-061755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122061755/doc4.xml","form_type":"4"}},{"id":2083736,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-17T01:49:24.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 3,471 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.."}],"balance_after":69512,"source":{"system":"sec-edgar","filing":"0001209191-22-061755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122061755/doc4.xml","form_type":"4"}},{"id":2203963,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":108750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":108750,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":108750},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203962,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":90000,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203961,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":86250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3rd) of the shares subject to the option shall vest on July 20, 2023, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":86250,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":86250},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203960,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":207500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3rd) of the shares subject to the option shall vest on July 20, 2023, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":207500,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":207500},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203959,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":108750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty five percent (25%) of the shares subject to the option would have vested on February 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option would have vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":9.48,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":108750},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203958,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty five percent (25%) of the shares subject to the option vested on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":29.83,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203957,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":86250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty five percent (25%) of the shares subject to the option vested on April 23, 2021, and one forty-eighth (1/48th) of the shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":86250},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2203956,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:07:20.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":207500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the option vested on September 10, 2020, and one forty-eighth (1/48th) of the shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":6.44,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":207500},"source":{"system":"sec-edgar","filing":"0001209191-22-042842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122042842/doc4.xml","form_type":"4"}},{"id":2312970,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-01T00:51:58.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":60000,"price":5.3604,"value":321624.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 60,000 shares purchased in the price range of $5.25 to $5.46 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-22-021875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122021875/doc4.xml","form_type":"4"}},{"id":2416756,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-02T21:07:15.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":18125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":18125,"derivative":{"underlying":"Common Stock","underlying_shares":18125},"source":{"system":"sec-edgar","filing":"0001209191-22-006337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122006337/doc4.xml","form_type":"4"}},{"id":2416755,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T21:07:15.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":108750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2023, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":108750,"derivative":{"exercise_price":9.48,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":108750},"source":{"system":"sec-edgar","filing":"0001209191-22-006337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919122006337/doc4.xml","form_type":"4"}},{"id":2885822,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T00:32:02.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2022, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":90000,"derivative":{"exercise_price":29.83,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-006964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919121006964/doc4.xml","form_type":"4"}},{"id":3169104,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-27T20:42:37.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":86250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter."}],"balance_after":86250,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":86250},"source":{"system":"sec-edgar","filing":"0001209191-20-025808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919120025808/doc4.xml","form_type":"4"}},{"id":3666056,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-11T22:33:22.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 8, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":68.89,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-009034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919119009034/doc4.xml","form_type":"4"}},{"id":3743840,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 9, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"In addition to the remaining options to purchase 133,241 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 98,000 shares of common stock, which options vest according to their terms."}],"balance_after":133241,"derivative":{"exercise_price":11.34,"expiration_date":"2027-01-07","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743839,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":1100,"price":75.8091,"value":83390.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.44 to $76.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743838,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":6624,"price":74.33,"value":492361.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.00 to $74.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743837,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":2298,"price":73.1761,"value":168158.6778,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.93 to $73.28 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7724,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743836,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":4820,"price":72.2432,"value":348212.224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.91 to $72.90 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10022,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743835,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":18604,"price":71.332,"value":1327060.528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.90 to $71.88 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14842,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743834,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":3554,"price":70.336,"value":249974.144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.90 to $70.86 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":33446,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":3743833,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-05T02:33:15.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":37000,"price":11.34,"value":419580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":37000,"source":{"system":"sec-edgar","filing":"0001209191-18-061100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118061100/doc4.xml","form_type":"4"}},{"id":4084958,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-30T21:16:49.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 26, 2019, and thereafter vests as to\n1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the\nReporting Person on each vesting date."}],"balance_after":23000,"derivative":{"exercise_price":106.84,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-18-006000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919118006000/doc4.xml","form_type":"4"}},{"id":4418042,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-28T23:44:26.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to\n1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the\nReporting Person on each vesting date."}],"balance_after":75000,"derivative":{"exercise_price":24.6,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-015447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000120919117015447/doc4.xml","form_type":"4"}}]}